| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | P-type sodium transporter activity | 9.97e-09 | 10 | 169 | 5 | GO:0008554 | |
| GeneOntologyMolecularFunction | P-type sodium:potassium-exchanging transporter activity | 9.97e-09 | 10 | 169 | 5 | GO:0005391 | |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 1.81e-08 | 11 | 169 | 5 | GO:0008556 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | NPHS1 NOP56 DSP TNC LAMA5 ESAM ADGRL1 ITGB2 PTPRB TENM3 ICAM5 EIF2S3 TENM1 ROBO3 ENO1 HCFC1 SDCBP CDH12 CDH17 | 8.16e-07 | 599 | 169 | 19 | GO:0050839 |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 1.25e-05 | 36 | 169 | 5 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 1.25e-05 | 36 | 169 | 5 | GO:0015662 | |
| GeneOntologyMolecularFunction | calcium ion binding | HSPG2 FAT4 SPARC PCDHGC5 PCDHGC4 DSPP SRR CLSTN1 PCDH20 FAT1 HMCN1 LRP1 LRP4 NID1 DSG4 CDH12 CDH17 CDHR4 | 6.80e-05 | 749 | 169 | 18 | GO:0005509 |
| GeneOntologyMolecularFunction | proteoglycan binding | 7.02e-05 | 51 | 169 | 5 | GO:0043394 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 1.79e-04 | 62 | 169 | 5 | GO:0019829 | |
| GeneOntologyMolecularFunction | spectrin binding | 1.88e-04 | 34 | 169 | 4 | GO:0030507 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.04e-04 | 188 | 169 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | P-type potassium:proton transporter activity | 2.12e-04 | 3 | 169 | 2 | GO:0008900 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 3.32e-04 | 109 | 169 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 3.71e-04 | 17 | 169 | 3 | GO:0042813 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 7.21e-04 | 48 | 169 | 4 | GO:0016620 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 8.71e-04 | 180 | 169 | 7 | GO:0004866 | |
| GeneOntologyMolecularFunction | translation initiation factor activity | 9.08e-04 | 51 | 169 | 4 | GO:0003743 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 1.09e-03 | 187 | 169 | 7 | GO:0030414 | |
| GeneOntologyMolecularFunction | opsonin binding | 1.19e-03 | 25 | 169 | 3 | GO:0001846 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 1.29e-03 | 56 | 169 | 4 | GO:0016903 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 1.33e-03 | 310 | 169 | 9 | GO:0030246 | |
| GeneOntologyMolecularFunction | steroid hormone binding | 1.45e-03 | 7 | 169 | 2 | GO:1990239 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 1.65e-03 | 201 | 169 | 7 | GO:0061135 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 1.76e-03 | 102 | 169 | 5 | GO:0001540 | |
| GeneOntologyMolecularFunction | interleukin-17 receptor activity | 1.93e-03 | 8 | 169 | 2 | GO:0030368 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | NPHS1 MICAL1 TRIM2 KIF26A CORO1C SLC26A5 DPYSL4 MIB2 ANKRD23 CLSTN1 CCDC88B SPAG6 OPHN1 PTPRN SIPA1L1 ATP1A1 EPB41 CAP2 KLHL17 | 2.46e-03 | 1099 | 169 | 19 | GO:0008092 |
| GeneOntologyMolecularFunction | syndecan binding | 2.47e-03 | 9 | 169 | 2 | GO:0045545 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 2.47e-03 | 32 | 169 | 3 | GO:0005452 | |
| GeneOntologyMolecularFunction | complement binding | 2.47e-03 | 32 | 169 | 3 | GO:0001848 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCC1 SLC25A14 SLC26A5 SLC25A30 ATP1A1 ATP1A3 ATP12A SLC41A1 ATP1A4 ATP4A CDH17 | 2.53e-03 | 477 | 169 | 11 | GO:0022804 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | FAT4 PCDHGC5 PCDHGC4 ESAM CLSTN1 PCDH20 FAT1 HMCN1 TENM3 PKD1 DSG4 ROBO3 CDH12 CDH17 CDHR4 | 3.44e-11 | 187 | 167 | 15 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | FAT4 PCDHGC5 PCDHGC4 ESAM ADGRL1 CLSTN1 ITGB2 PCDH20 FAT1 HMCN1 TENM3 PKD1 TENM1 DSG4 ROBO3 CDH12 CDH17 CDHR4 | 8.98e-11 | 313 | 167 | 18 | GO:0098742 |
| GeneOntologyBiologicalProcess | establishment or maintenance of transmembrane electrochemical gradient | 1.46e-08 | 11 | 167 | 5 | GO:0010248 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | NPHS1 FAT4 PCDHGC5 PCDHGC4 DSP DOCK8 ESAM ADGRL1 NCAM1 AP3B1 CLSTN1 CCDC88B ITGB2 PCDH20 FAT1 HMCN1 TENM3 ICAM5 PKD1 PKHD1 TENM1 LRP5 DSG4 ROBO3 CDH12 CDH17 CDHR4 | 1.58e-07 | 1077 | 167 | 27 | GO:0098609 |
| GeneOntologyBiologicalProcess | intracellular potassium ion homeostasis | 1.87e-07 | 17 | 167 | 5 | GO:0030007 | |
| GeneOntologyBiologicalProcess | sodium ion export across plasma membrane | 1.87e-07 | 17 | 167 | 5 | GO:0036376 | |
| GeneOntologyBiologicalProcess | cell junction organization | NPHS1 SPARC PCDHGC5 PCDHGC4 DSP TNC CORO1C LAMA5 ESAM ADGRL1 CLSTN1 OPHN1 SHANK2 TENM3 ICAM5 SIPA1L1 PKHD1 LRP1 LRP4 LRP5 SDCBP CDH12 PLXNB1 CAP2 CDH17 | 3.12e-07 | 974 | 167 | 25 | GO:0034330 |
| GeneOntologyBiologicalProcess | sodium ion homeostasis | 3.43e-06 | 51 | 167 | 6 | GO:0055078 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | SART3 HSPG2 SPARC ARHGEF28 CORO1C SLC26A5 VSIG1 LAMA5 NCAM1 AP3B1 SPAG6 ITGB2 EDN1 OPHN1 FAT1 HECW2 SIPA1L1 PKHD1 LRP1 LRP4 ROBO3 CDH12 EPB41 PLXNB1 CAP2 CDH17 | 3.83e-06 | 1194 | 167 | 26 | GO:0000902 |
| GeneOntologyBiologicalProcess | intracellular sodium ion homeostasis | 3.96e-06 | 30 | 167 | 5 | GO:0006883 | |
| GeneOntologyBiologicalProcess | potassium ion homeostasis | 1.16e-05 | 37 | 167 | 5 | GO:0055075 | |
| GeneOntologyBiologicalProcess | morphogenesis of a polarized epithelium | 2.80e-05 | 73 | 167 | 6 | GO:0001738 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 4.23e-05 | 9 | 167 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | synapse organization | SPARC PCDHGC5 PCDHGC4 TNC LAMA5 ADGRL1 CLSTN1 OPHN1 SHANK2 TENM3 ICAM5 SIPA1L1 LRP4 LRP5 SDCBP PLXNB1 CAP2 | 4.29e-05 | 685 | 167 | 17 | GO:0050808 |
| GeneOntologyBiologicalProcess | actin filament-based process | NPHS1 MICAL1 KRT19 DSP CORO1C ESAM ANKRD23 SPAG6 EDN1 OPHN1 FAT1 HMCN1 SIPA1L1 TENM1 LRP1 ATP1A1 SDCBP EPB41 CAP2 KLHL17 | 5.07e-05 | 912 | 167 | 20 | GO:0030029 |
| GeneOntologyBiologicalProcess | potassium ion import across plasma membrane | 5.70e-05 | 51 | 167 | 5 | GO:1990573 | |
| GeneOntologyBiologicalProcess | import into cell | ABCC1 HSPG2 CORO1C TBC1D2B FCHO2 ITGB2 OPHN1 PROM2 ICAM5 LRP1 AHSG LRP4 LRP5 KCNQ3 C4A C4B ATP1A1 ATP1A3 ATP12A ATP1A4 ATP4A SDCBP | 5.76e-05 | 1074 | 167 | 22 | GO:0098657 |
| GeneOntologyBiologicalProcess | formation of translation preinitiation complex | 6.00e-05 | 10 | 167 | 3 | GO:0001731 | |
| GeneOntologyBiologicalProcess | cell junction assembly | NPHS1 CORO1C ESAM ADGRL1 CLSTN1 OPHN1 SHANK2 ICAM5 SIPA1L1 LRP1 LRP4 SDCBP CDH12 PLXNB1 CDH17 | 6.30e-05 | 569 | 167 | 15 | GO:0034329 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | NPHS1 MICAL1 KRT19 CORO1C ESAM ANKRD23 SPAG6 EDN1 OPHN1 FAT1 HMCN1 SIPA1L1 TENM1 LRP1 SDCBP EPB41 CAP2 KLHL17 | 9.36e-05 | 803 | 167 | 18 | GO:0030036 |
| GeneOntologyBiologicalProcess | export across plasma membrane | 9.72e-05 | 91 | 167 | 6 | GO:0140115 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 1.58e-04 | 63 | 167 | 5 | GO:0007157 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 2.16e-04 | 198 | 167 | 8 | GO:0048754 | |
| GeneOntologyBiologicalProcess | establishment of epithelial cell polarity | 3.65e-04 | 42 | 167 | 4 | GO:0090162 | |
| GeneOntologyCellularComponent | extracellular matrix | A2M NPHS1 HSPG2 COL11A2 SPARC DSPP TNC LAMA5 NCAM1 ITIH2 FCGBP HMCN1 AHSG SDC3 NID1 PZP HCFC1 OTOG | 5.95e-06 | 656 | 168 | 18 | GO:0031012 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | A2M NPHS1 HSPG2 COL11A2 SPARC DSPP TNC LAMA5 NCAM1 ITIH2 HMCN1 AHSG SDC3 NID1 PZP HCFC1 | 6.18e-06 | 530 | 168 | 16 | GO:0062023 |
| GeneOntologyCellularComponent | external encapsulating structure | A2M NPHS1 HSPG2 COL11A2 SPARC DSPP TNC LAMA5 NCAM1 ITIH2 FCGBP HMCN1 AHSG SDC3 NID1 PZP HCFC1 OTOG | 6.21e-06 | 658 | 168 | 18 | GO:0030312 |
| GeneOntologyCellularComponent | basolateral plasma membrane | ABCC1 DSP SLC26A5 VSIG1 PROM2 PKD1 LRP1 ATP1A1 ATP12A SLC41A1 EPB41 CDH17 | 1.13e-05 | 320 | 168 | 12 | GO:0016323 |
| GeneOntologyCellularComponent | basal part of cell | ABCC1 DSP SLC26A5 VSIG1 EDN1 PROM2 PKD1 LRP1 ATP1A1 ATP12A SLC41A1 EPB41 CDH17 | 1.22e-05 | 378 | 168 | 13 | GO:0045178 |
| GeneOntologyCellularComponent | basal plasma membrane | ABCC1 DSP SLC26A5 VSIG1 PROM2 PKD1 LRP1 ATP1A1 ATP12A SLC41A1 EPB41 CDH17 | 3.07e-05 | 354 | 168 | 12 | GO:0009925 |
| GeneOntologyCellularComponent | multi-pass translocon complex | 4.13e-05 | 9 | 168 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | cation-transporting ATPase complex | 4.53e-05 | 49 | 168 | 5 | GO:0090533 | |
| GeneOntologyCellularComponent | basement membrane | 5.90e-05 | 122 | 168 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | lateral wall of outer hair cell | 6.42e-05 | 2 | 168 | 2 | GO:0120249 | |
| GeneOntologyCellularComponent | ATPase dependent transmembrane transport complex | 7.94e-05 | 55 | 168 | 5 | GO:0098533 | |
| GeneOntologyCellularComponent | sodium:potassium-exchanging ATPase complex | 1.06e-04 | 12 | 168 | 3 | GO:0005890 | |
| GeneOntologyCellularComponent | blood microparticle | 1.67e-04 | 144 | 168 | 7 | GO:0072562 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 1.74e-04 | 14 | 168 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | potassium:proton exchanging ATPase complex | 1.92e-04 | 3 | 168 | 2 | GO:0005889 | |
| GeneOntologyCellularComponent | axon | MICAL1 ADGRL1 NCAM1 AP3B1 OPHN1 SHANK2 TENM3 PTPRN LRP1 SDC3 KCNQ3 C4A C4B ATP1A1 ROBO3 ATP1A3 ENO1 HCFC1 | 3.08e-04 | 891 | 168 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | anchoring junction | NPHS1 HSPG2 DSP TNC CORO1C ESAM NCAM1 ANKRD23 ITGB2 FAT1 HMCN1 LRP1 DSG4 ATP1A1 CD99L2 HSPA9 SDCBP CDH12 CDH17 | 3.31e-04 | 976 | 168 | 19 | GO:0070161 |
| GeneOntologyCellularComponent | photoreceptor inner segment membrane | 3.81e-04 | 4 | 168 | 2 | GO:0060342 | |
| GeneOntologyCellularComponent | microspike | 3.81e-04 | 4 | 168 | 2 | GO:0044393 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | HSPG2 HTRA2 KRT19 CORO1C ITGB2 LRP1 LRP5 KCNQ3 ATP1A1 ATP1A3 ATP12A ATP1A4 ATP4A SDCBP CDH12 CDH17 | 6.10e-04 | 785 | 168 | 16 | GO:0098797 |
| GeneOntologyCellularComponent | lateral plasma membrane | 8.00e-04 | 90 | 168 | 5 | GO:0016328 | |
| GeneOntologyCellularComponent | cell-substrate junction | NPHS1 HSPG2 TNC CORO1C ITGB2 FAT1 HMCN1 LRP1 CD99L2 HSPA9 SDCBP | 9.41e-04 | 443 | 168 | 11 | GO:0030055 |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 2 complex | 9.43e-04 | 6 | 168 | 2 | GO:0005850 | |
| GeneOntologyCellularComponent | cell-cell junction | NPHS1 DSP ESAM NCAM1 ANKRD23 FAT1 HMCN1 DSG4 ATP1A1 CD99L2 SDCBP CDH12 CDH17 | 1.01e-03 | 591 | 168 | 13 | GO:0005911 |
| GeneOntologyCellularComponent | adherens junction | 1.67e-03 | 212 | 168 | 7 | GO:0005912 | |
| GeneOntologyCellularComponent | dynactin complex | 1.74e-03 | 8 | 168 | 2 | GO:0005869 | |
| GeneOntologyCellularComponent | symbiont cell surface | 1.74e-03 | 8 | 168 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | lateral part of cell | 1.74e-03 | 8 | 168 | 2 | GO:0097574 | |
| GeneOntologyCellularComponent | myelin sheath | 1.90e-03 | 217 | 168 | 7 | GO:0043209 | |
| GeneOntologyCellularComponent | other organism part | 2.23e-03 | 9 | 168 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | focal adhesion | 2.62e-03 | 431 | 168 | 10 | GO:0005925 | |
| GeneOntologyCellularComponent | apical part of cell | ABCC1 FAT4 SRR FAT1 SHANK2 PROM2 PKHD1 LRP1 ATP1A1 ATP12A ATP4A OTOG | 3.07e-03 | 592 | 168 | 12 | GO:0045177 |
| Domain | P-type_ATPase_IIC | 3.21e-10 | 6 | 167 | 5 | IPR005775 | |
| Domain | - | 1.68e-09 | 39 | 167 | 8 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 6.75e-09 | 46 | 167 | 8 | IPR011042 | |
| Domain | EGF-like_dom | HSPG2 FAT4 TNC LAMA5 FAT1 CNTNAP5 FCGBP HMCN1 TENM3 TENM1 LRP1 LRP4 LRP5 NID1 OTOG | 7.10e-09 | 249 | 167 | 15 | IPR000742 |
| Domain | A2M | 1.31e-08 | 10 | 167 | 5 | PF00207 | |
| Domain | A2M_N_2 | 1.31e-08 | 10 | 167 | 5 | IPR011625 | |
| Domain | A2M_comp | 1.31e-08 | 10 | 167 | 5 | IPR011626 | |
| Domain | A2M_recep | 1.31e-08 | 10 | 167 | 5 | PF07677 | |
| Domain | A2M_comp | 1.31e-08 | 10 | 167 | 5 | PF07678 | |
| Domain | A2M_N | 1.31e-08 | 10 | 167 | 5 | PF01835 | |
| Domain | A2M_N | 1.31e-08 | 10 | 167 | 5 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.31e-08 | 10 | 167 | 5 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.31e-08 | 10 | 167 | 5 | PS00477 | |
| Domain | A2M_N_2 | 1.31e-08 | 10 | 167 | 5 | PF07703 | |
| Domain | Macroglobln_a2 | 1.31e-08 | 10 | 167 | 5 | IPR001599 | |
| Domain | EGF | HSPG2 FAT4 TNC LAMA5 FAT1 CNTNAP5 FCGBP HMCN1 TENM3 TENM1 LRP1 LRP4 LRP5 NID1 | 2.65e-08 | 235 | 167 | 14 | SM00181 |
| Domain | CADHERIN_1 | FAT4 PCDHGC5 PCDHGC4 CLSTN1 PCDH20 FAT1 DSG4 CDH12 CDH17 CDHR4 | 7.01e-08 | 113 | 167 | 10 | PS00232 |
| Domain | Cadherin | FAT4 PCDHGC5 PCDHGC4 CLSTN1 PCDH20 FAT1 DSG4 CDH12 CDH17 CDHR4 | 7.01e-08 | 113 | 167 | 10 | PF00028 |
| Domain | EGF_1 | HSPG2 FAT4 TNC LAMA5 ITGB2 FAT1 CNTNAP5 HMCN1 TENM3 TENM1 LRP1 LRP4 LRP5 NID1 | 7.36e-08 | 255 | 167 | 14 | PS00022 |
| Domain | CADHERIN_2 | FAT4 PCDHGC5 PCDHGC4 CLSTN1 PCDH20 FAT1 DSG4 CDH12 CDH17 CDHR4 | 7.63e-08 | 114 | 167 | 10 | PS50268 |
| Domain | - | FAT4 PCDHGC5 PCDHGC4 CLSTN1 PCDH20 FAT1 DSG4 CDH12 CDH17 CDHR4 | 7.63e-08 | 114 | 167 | 10 | 2.60.40.60 |
| Domain | CA | FAT4 PCDHGC5 PCDHGC4 CLSTN1 PCDH20 FAT1 DSG4 CDH12 CDH17 CDHR4 | 8.29e-08 | 115 | 167 | 10 | SM00112 |
| Domain | Cadherin-like | FAT4 PCDHGC5 PCDHGC4 CLSTN1 PCDH20 FAT1 DSG4 CDH12 CDH17 CDHR4 | 9.00e-08 | 116 | 167 | 10 | IPR015919 |
| Domain | Cadherin | FAT4 PCDHGC5 PCDHGC4 CLSTN1 PCDH20 FAT1 DSG4 CDH12 CDH17 CDHR4 | 1.06e-07 | 118 | 167 | 10 | IPR002126 |
| Domain | EGF_2 | HSPG2 FAT4 TNC LAMA5 ITGB2 FAT1 CNTNAP5 HMCN1 TENM3 TENM1 LRP1 LRP4 LRP5 NID1 | 1.18e-07 | 265 | 167 | 14 | PS01186 |
| Domain | EGF_3 | HSPG2 FAT4 TNC FAT1 CNTNAP5 HMCN1 TENM3 TENM1 LRP1 LRP4 LRP5 NID1 OTOG | 2.01e-07 | 235 | 167 | 13 | PS50026 |
| Domain | ATPase_P-typ_TM_dom | 2.17e-07 | 16 | 167 | 5 | IPR023298 | |
| Domain | - | 2.17e-07 | 16 | 167 | 5 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 3.05e-07 | 17 | 167 | 5 | IPR006068 | |
| Domain | Cation_ATPase_C | 3.05e-07 | 17 | 167 | 5 | PF00689 | |
| Domain | CarboxyPept-like_regulatory | 3.05e-07 | 17 | 167 | 5 | IPR008969 | |
| Domain | Cation_ATPase_N | 4.20e-07 | 18 | 167 | 5 | PF00690 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 4.20e-07 | 18 | 167 | 5 | IPR008930 | |
| Domain | Cation_ATPase_N | 4.20e-07 | 18 | 167 | 5 | SM00831 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 4.20e-07 | 8 | 167 | 4 | IPR019565 | |
| Domain | Carb-bd-like_fold | 4.20e-07 | 8 | 167 | 4 | IPR013784 | |
| Domain | Thiol-ester_cl | 4.20e-07 | 8 | 167 | 4 | PF10569 | |
| Domain | MacrogloblnA2_CS | 4.20e-07 | 8 | 167 | 4 | IPR019742 | |
| Domain | ATPase_P-typ_cation-transptr_N | 5.66e-07 | 19 | 167 | 5 | IPR004014 | |
| Domain | Cadherin_CS | 5.84e-07 | 109 | 167 | 9 | IPR020894 | |
| Domain | EGF-like_CS | HSPG2 FAT4 TNC LAMA5 ITGB2 FAT1 HMCN1 TENM3 TENM1 LRP1 LRP4 LRP5 NID1 | 6.65e-07 | 261 | 167 | 13 | IPR013032 |
| Domain | Laminin_G_2 | 1.39e-06 | 40 | 167 | 6 | PF02210 | |
| Domain | LamG | 2.49e-06 | 44 | 167 | 6 | SM00282 | |
| Domain | DUF2012 | 2.79e-06 | 4 | 167 | 3 | PF09430 | |
| Domain | DUF2012 | 2.79e-06 | 4 | 167 | 3 | IPR019008 | |
| Domain | CarboxyPept_regulatory_dom | 4.14e-06 | 13 | 167 | 4 | IPR014766 | |
| Domain | - | 4.14e-06 | 13 | 167 | 4 | 2.60.40.1120 | |
| Domain | NHL | 4.14e-06 | 13 | 167 | 4 | PS51125 | |
| Domain | Ig-like_fold | NPHS1 HSPG2 TRIM2 TNC VSIG1 ESAM NCAM1 TRIM3 NOMO1 CILP2 PTPRB SHANK2 HMCN1 NOMO2 ICAM5 PKHD1 ROBO3 HCFC1 NOMO3 PLXNB1 | 5.28e-06 | 706 | 167 | 20 | IPR013783 |
| Domain | Ldl_recept_b | 5.76e-06 | 14 | 167 | 4 | PF00058 | |
| Domain | LDLRB | 5.76e-06 | 14 | 167 | 4 | PS51120 | |
| Domain | LY | 7.79e-06 | 15 | 167 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 7.79e-06 | 15 | 167 | 4 | IPR000033 | |
| Domain | - | NPHS1 HSPG2 TRIM2 TNC VSIG1 ESAM NCAM1 TRIM3 NOMO1 CILP2 PTPRB HMCN1 NOMO2 ICAM5 PKHD1 ROBO3 HCFC1 NOMO3 PLXNB1 | 7.84e-06 | 663 | 167 | 19 | 2.60.40.10 |
| Domain | - | 8.92e-06 | 32 | 167 | 5 | 3.40.1110.10 | |
| Domain | - | 8.92e-06 | 32 | 167 | 5 | 2.70.150.10 | |
| Domain | Growth_fac_rcpt_ | 1.14e-05 | 156 | 167 | 9 | IPR009030 | |
| Domain | Laminin_G | 1.29e-05 | 58 | 167 | 6 | IPR001791 | |
| Domain | ATPase_P-typ_cyto_domN | 1.41e-05 | 35 | 167 | 5 | IPR023299 | |
| Domain | EGF-like_Ca-bd_dom | 1.58e-05 | 124 | 167 | 8 | IPR001881 | |
| Domain | ATPase_P-typ_P_site | 1.62e-05 | 36 | 167 | 5 | IPR018303 | |
| Domain | P_typ_ATPase | 1.62e-05 | 36 | 167 | 5 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.62e-05 | 36 | 167 | 5 | PS00154 | |
| Domain | EGF | 1.77e-05 | 126 | 167 | 8 | PF00008 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.86e-05 | 37 | 167 | 5 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.86e-05 | 37 | 167 | 5 | PF00122 | |
| Domain | LAM_G_DOMAIN | 2.13e-05 | 38 | 167 | 5 | PS50025 | |
| Domain | - | 2.30e-05 | 95 | 167 | 7 | 2.60.120.200 | |
| Domain | EGF_CA | 3.01e-05 | 99 | 167 | 7 | PS01187 | |
| Domain | A2M_N_2 | 3.80e-05 | 8 | 167 | 3 | SM01359 | |
| Domain | - | 3.80e-05 | 8 | 167 | 3 | 2.60.40.690 | |
| Domain | A2M_recep | 3.80e-05 | 8 | 167 | 3 | SM01361 | |
| Domain | A2M | 3.80e-05 | 8 | 167 | 3 | SM01360 | |
| Domain | Ig_E-set | 4.13e-05 | 104 | 167 | 7 | IPR014756 | |
| Domain | LDLRA_1 | 6.75e-05 | 48 | 167 | 5 | PS01209 | |
| Domain | LDLRA_2 | 7.47e-05 | 49 | 167 | 5 | PS50068 | |
| Domain | cEGF | 7.91e-05 | 26 | 167 | 4 | PF12662 | |
| Domain | cEGF | 7.91e-05 | 26 | 167 | 4 | IPR026823 | |
| Domain | Arp1 | 7.95e-05 | 2 | 167 | 2 | IPR029909 | |
| Domain | EGF_CA | 1.14e-04 | 122 | 167 | 7 | SM00179 | |
| Domain | EGF_CA | 1.22e-04 | 86 | 167 | 6 | PF07645 | |
| Domain | - | 1.46e-04 | 12 | 167 | 3 | 1.50.10.20 | |
| Domain | EGF_Ca-bd_CS | 2.36e-04 | 97 | 167 | 6 | IPR018097 | |
| Domain | G2F | 2.37e-04 | 3 | 167 | 2 | SM00682 | |
| Domain | IGc2 | 2.71e-04 | 235 | 167 | 9 | SM00408 | |
| Domain | Ig_sub2 | 2.71e-04 | 235 | 167 | 9 | IPR003598 | |
| Domain | ASX_HYDROXYL | 2.78e-04 | 100 | 167 | 6 | PS00010 | |
| Domain | Ig_I-set | 3.16e-04 | 190 | 167 | 8 | IPR013098 | |
| Domain | I-set | 3.16e-04 | 190 | 167 | 8 | PF07679 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.81e-04 | 106 | 167 | 6 | IPR000152 | |
| Domain | LDLR_class-A_CS | 4.38e-04 | 40 | 167 | 4 | IPR023415 | |
| Domain | - | 4.71e-04 | 4 | 167 | 2 | 3.90.1460.10 | |
| Domain | Tox-GHH_dom | 4.71e-04 | 4 | 167 | 2 | IPR028916 | |
| Domain | Neural_cell_adh | 4.71e-04 | 4 | 167 | 2 | IPR009138 | |
| Domain | G2F | 4.71e-04 | 4 | 167 | 2 | PF07474 | |
| Domain | Tox-GHH | 4.71e-04 | 4 | 167 | 2 | PF15636 | |
| Domain | NIDOGEN_G2 | 4.71e-04 | 4 | 167 | 2 | PS50993 | |
| Domain | GFP | 4.71e-04 | 4 | 167 | 2 | IPR009017 | |
| Domain | Ten_N | 4.71e-04 | 4 | 167 | 2 | IPR009471 | |
| Domain | Ten_N | 4.71e-04 | 4 | 167 | 2 | PF06484 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | A2M HSPG2 COL11A2 SPARC DSPP TNC LAMA5 NCAM1 ITGB2 ICAM5 LRP4 SDC3 NID1 | 3.99e-06 | 300 | 130 | 13 | M610 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 6.21e-06 | 76 | 130 | 7 | M27219 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.48e-04 | 55 | 130 | 5 | M971 | |
| Pathway | REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR | 1.59e-04 | 12 | 130 | 3 | MM14981 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.76e-04 | 57 | 130 | 5 | MM15643 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.07e-04 | 59 | 130 | 5 | M27218 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ATMIN HSPG2 SH3RF1 EP400 KIF26A MTHFD1L LAMA5 ADGRL1 MIB2 NHSL1 ACTR1A KMT2C FAT1 SHANK2 PROM2 TMEM132A PKD1 ANKRD11 LRP4 LRP5 MAPKBP1 ARRDC2 SPEN MYRF D2HGDH HCFC1 KLHL17 | 5.95e-12 | 1105 | 170 | 27 | 35748872 |
| Pubmed | SART3 MICAL1 KRT19 DSP DOCK8 TNC CORO1C DPYSL4 ADGRL1 NCAM1 EIF2S3B AP3B1 TRIM3 OPHN1 NHSL1 ACTR1A SHANK2 ICAM5 HECW2 EIF2S3 SIPA1L1 DLD KCNQ3 C4A C4B ATP1A1 ATP1A3 HSPA9 SDCBP ALDH7A1 | 1.56e-11 | 1431 | 170 | 30 | 37142655 | |
| Pubmed | 1.57e-11 | 6 | 170 | 5 | 3036582 | ||
| Pubmed | Multiple genes encode the human Na+,K+-ATPase catalytic subunit. | 2.74e-09 | 5 | 170 | 4 | 3035563 | |
| Pubmed | A2M HSPG2 TNC NCAM1 ITGB2 ITIH2 FCGBP LRP1 AHSG C4A PZP PLXNB1 | 5.97e-09 | 257 | 170 | 12 | 16335952 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | A2M HSPG2 FAT4 ACO1 LAMA5 ITIH2 ACTR1B ACTR1A CILP2 FCGBP HMCN1 PROM2 QPRT TMEM132A AHSG NID1 C4A C4B PZP ENO1 SDCBP ALDH7A1 | 1.49e-08 | 1070 | 170 | 22 | 23533145 |
| Pubmed | CORO1C DPYSL4 NCAM1 NOMO1 ACTR1A NOMO2 DLD C4A C4B ATP1A1 ATP1A3 ENO1 HSPA9 EPB41 NOMO3 | 1.03e-07 | 552 | 170 | 15 | 36293380 | |
| Pubmed | Generation of a conditionally null allele of the laminin alpha1 gene. | 1.13e-07 | 10 | 170 | 4 | 16100707 | |
| Pubmed | Identification of a VxP Targeting Signal in the Flagellar Na+ /K+ -ATPase. | 1.15e-07 | 3 | 170 | 3 | 26373354 | |
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 36011023 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 1.15e-07 | 3 | 170 | 3 | 25576386 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | NOP56 MTHFD1L CORO1C TBC1D2B KMT2C PTPRB ANKRD11 NID1 C4A C4B ATP1A1 SH3RF3 HCFC1 SDCBP | 1.81e-07 | 497 | 170 | 14 | 36774506 |
| Pubmed | 2.11e-07 | 52 | 170 | 6 | 20114047 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | KRT19 DSP MTHFD1L CORO1C DPYSL4 FCHO2 ACTR1B ACTR1A EIF2D NOMO2 SIPA1L1 DLD ATP1A1 PCCA HSPA9 EPB41 ALDH7A1 FTSJ3 | 2.29e-07 | 853 | 170 | 18 | 28718761 |
| Pubmed | FAT4 NOP56 PCDHGC5 CORO1C CSMD3 ACTR1A EIF2S3 TENM1 AHSG NID1 DSG4 ENO1 HCFC1 HSPA9 | 2.65e-07 | 513 | 170 | 14 | 25798074 | |
| Pubmed | 2.84e-07 | 29 | 170 | 5 | 15071553 | ||
| Pubmed | 3.64e-07 | 92 | 170 | 7 | 37343697 | ||
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 21849490 | ||
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 4.57e-07 | 4 | 170 | 3 | 31833031 | |
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 2887455 | ||
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 9267806 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | DOCK8 NCAM1 EIF2S3B TRIM3 ACTR1B ICAM5 EIF2S3 SIPA1L1 DLD ATP1A1 ATP12A ATP1A4 ENO1 ATP4A HSPA9 | 4.60e-07 | 621 | 170 | 15 | 22794259 |
| Pubmed | A2M SART3 ARHGEF28 MIB2 AP3B1 CLSTN1 RUSC2 EIF2D MTIF2 EIF2S3 C4A C4B PZP HCFC1 PLXNB1 | 8.13e-07 | 650 | 170 | 15 | 38777146 | |
| Pubmed | EXOSC9 HIVEP1 SH3RF1 KRT19 DSP KIF26A MKNK2 ADGRL1 CCDC88B KMT2C ATF6 C4A CAP2 | 8.98e-07 | 486 | 170 | 13 | 20936779 | |
| Pubmed | Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation. | 9.58e-07 | 16 | 170 | 4 | 21067603 | |
| Pubmed | ABCC1 CCDC8 NOP56 MTHFD1L NCAM1 TRAPPC8 NOMO1 HSPA13 ATF6 FAT1 NOMO2 RHBDD3 ATP1A1 PCCA CD99L2 HSPA9 EPB41 NOMO3 | 1.11e-06 | 952 | 170 | 18 | 38569033 | |
| Pubmed | 1.14e-06 | 5 | 170 | 3 | 9524110 | ||
| Pubmed | 1.14e-06 | 5 | 170 | 3 | 7514554 | ||
| Pubmed | Ouabain inhibits tubuloglomerular feedback in mutant mice with ouabain-sensitive alpha1 Na,K-ATPase. | 1.14e-06 | 5 | 170 | 3 | 16870707 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | NOP56 MTHFD1L CORO1C ITGB2 NOMO1 NOMO2 ATP1A1 ENO1 HCFC1 HSPA9 NOMO3 | 1.15e-06 | 344 | 170 | 11 | 30333137 |
| Pubmed | 1.37e-06 | 71 | 170 | 6 | 12754519 | ||
| Pubmed | A2M HSPG2 HIVEP1 DOCK8 LAMA5 NOMO1 TENM3 PKD1 LRP1 LRP5 NID1 SDCBP NOMO3 CAP2 | 1.42e-06 | 591 | 170 | 14 | 15231748 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 1.45e-06 | 219 | 170 | 9 | 31353912 | |
| Pubmed | FAT4 CCDC8 EP400 KRT19 NCAM1 AP3B1 FAT1 TENM3 EIF2S3 AHSG RHBDD3 ATP1A1 SPEN PCCA HSPA9 EPB41 | 1.53e-06 | 777 | 170 | 16 | 35844135 | |
| Pubmed | Targeting a complex transcriptome: the construction of the mouse full-length cDNA encyclopedia. | 1.94e-06 | 292 | 170 | 10 | 12819125 | |
| Pubmed | SART3 HSPG2 FAT4 HIVEP1 HTRA2 EDN1 NOMO1 HSPA13 PTPRN MAPKBP1 ATP1A3 SPEN ENO1 NOMO3 | 1.97e-06 | 608 | 170 | 14 | 16713569 | |
| Pubmed | 2.27e-06 | 6 | 170 | 3 | 11956183 | ||
| Pubmed | 2.45e-06 | 44 | 170 | 5 | 31273033 | ||
| Pubmed | 2.56e-06 | 175 | 170 | 8 | 28071719 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 3.60e-06 | 313 | 170 | 10 | 38270169 | |
| Pubmed | 3.76e-06 | 130 | 170 | 7 | 12421765 | ||
| Pubmed | Differential involvement of Na(+),K(+)-ATPase isozymes in preimplantation development of the mouse. | 3.96e-06 | 7 | 170 | 3 | 10837135 | |
| Pubmed | 3.96e-06 | 7 | 170 | 3 | 2158121 | ||
| Pubmed | SART3 NOP56 KRT19 DSP DSPP AP3B1 ACTR1B ACTR1A KPNA7 GTF2IRD2B GTF2IRD2 ATP1A1 ATP1A3 ATP1A4 ENO1 HCFC1 ATP4A HSPA9 FTSJ3 | 4.10e-06 | 1153 | 170 | 19 | 29845934 | |
| Pubmed | 4.21e-06 | 49 | 170 | 5 | 21362503 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 4.25e-06 | 86 | 170 | 6 | 28327460 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 4.82e-06 | 135 | 170 | 7 | 28675934 | |
| Pubmed | Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool. | 5.42e-06 | 24 | 170 | 4 | 26116661 | |
| Pubmed | ABCC1 SPARC HTRA2 CORO1C PNPT1 ATF6 QPRT ALDH16A1 LRP1 LRP4 DLD ATP1A1 ENO1 HCFC1 HSPA9 ALDH7A1 | 5.46e-06 | 859 | 170 | 16 | 31536960 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | NOP56 KRT19 MTHFD1L CORO1C AP3B1 ACTR1B ACTR1A DLD ATP1A1 ATP1A3 SPEN HCFC1 HSPA9 FTSJ3 | 5.50e-06 | 665 | 170 | 14 | 30457570 |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 6.31e-06 | 8 | 170 | 3 | 15257293 | |
| Pubmed | 7.05e-06 | 143 | 170 | 7 | 22516433 | ||
| Pubmed | 7.28e-06 | 267 | 170 | 9 | 33417871 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ABCC1 HSPG2 FAT4 LAMA5 CLSTN1 NOMO1 HSPA13 ATF6 FAT1 TENM3 NOMO2 TMEM132A LRP1 LRP4 LRP5 NID1 C4A ATP1A1 PLXNB1 | 7.32e-06 | 1201 | 170 | 19 | 35696571 |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 7.73e-06 | 269 | 170 | 9 | 29511261 | |
| Pubmed | 8.07e-06 | 146 | 170 | 7 | 27068509 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 8.54e-06 | 97 | 170 | 6 | 27559042 | |
| Pubmed | Targeted inactivation of the mouse alpha 2-macroglobulin gene. | 9.43e-06 | 9 | 170 | 3 | 7544347 | |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 9.43e-06 | 9 | 170 | 3 | 36261522 | |
| Pubmed | LDL receptor-related protein as a component of the midkine receptor. | 9.43e-06 | 9 | 170 | 3 | 10772929 | |
| Pubmed | Dynamic expression patterns of ECM molecules in the developing mouse olfactory pathway. | 9.43e-06 | 9 | 170 | 3 | 18570250 | |
| Pubmed | Enhanced analysis of the mouse plasma proteome using cysteine-containing tryptic glycopeptides. | 1.06e-05 | 59 | 170 | 5 | 17330941 | |
| Pubmed | A2M HSPG2 LAMA5 NOMO1 ATF6 CILP2 NOMO2 ICAM5 LRP1 ATP1A1 ENO1 HSPA9 NOMO3 | 1.11e-05 | 613 | 170 | 13 | 22268729 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | NPHS1 HSPG2 DSP ACO1 LAMA5 RUSC2 ACTR1A FAT1 FCGBP BPI PROM2 PKD1 PKHD1 AHSG NID1 SPEN SDCBP | 1.11e-05 | 1016 | 170 | 17 | 19056867 |
| Pubmed | 1.12e-05 | 214 | 170 | 8 | 22199357 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | A2M DSP MTHFD1L ACO1 CORO1C DPYSL4 ACTR1A CDK5RAP3 FCGBP ALDH16A1 LRP1 DLD UPP1 ATP1A1 ENO1 PCCA HCFC1 HSPA9 EPB41 ALDH7A1 | 1.30e-05 | 1367 | 170 | 20 | 32687490 |
| Pubmed | 1.34e-05 | 10 | 170 | 3 | 12724416 | ||
| Pubmed | 1.34e-05 | 10 | 170 | 3 | 38713721 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATMIN CPAMD8 INPP5A ADGRL1 OPRL1 KMT2C ATF6 EXD3 PTPRB SHANK2 NACC2 PROM2 ANKRD11 LRP1 SDC3 LRP5 ARHGEF37 PCCA SH3RF3 EPB41 CAP2 | 1.34e-05 | 1489 | 170 | 21 | 28611215 |
| Pubmed | Human colostrum: identification of minor proteins in the aqueous phase by proteomics. | 1.59e-05 | 162 | 170 | 7 | 16502470 | |
| Pubmed | 1.76e-05 | 110 | 170 | 6 | 27889896 | ||
| Pubmed | NOP56 EP400 DSP CORO1C AP3B1 KMT2C ICAM5 SPEN ENO1 PCCA HCFC1 EPB41 | 1.82e-05 | 549 | 170 | 12 | 38280479 | |
| Pubmed | 1.84e-05 | 11 | 170 | 3 | 24639464 | ||
| Pubmed | 1.84e-05 | 11 | 170 | 3 | 19105203 | ||
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 1.84e-05 | 11 | 170 | 3 | 32820719 | |
| Pubmed | 1.93e-05 | 167 | 170 | 7 | 22159717 | ||
| Pubmed | Proteolipid protein is required for transport of sirtuin 2 into CNS myelin. | 2.09e-05 | 169 | 170 | 7 | 17634366 | |
| Pubmed | Large-scale identification of genes implicated in kidney glomerulus development and function. | 2.28e-05 | 34 | 170 | 4 | 16498405 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SART3 EXOSC9 HIVEP1 NOP56 HTRA2 DSP MTHFD1L CORO1C AP3B1 NOMO1 ACTR1A EIF2S3 DLD ATP1A1 SPEN ENO1 HCFC1 HSPA9 SDCBP FTSJ3 | 2.35e-05 | 1425 | 170 | 20 | 30948266 |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 2.38e-05 | 2 | 170 | 2 | 16565498 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 15998580 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 19062096 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 2.38e-05 | 2 | 170 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 2.38e-05 | 2 | 170 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 2.38e-05 | 2 | 170 | 2 | 17645767 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 12207352 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 23186781 | ||
| Pubmed | Mineralocorticoids stimulate the activity and expression of renal H+,K+-ATPases. | 2.38e-05 | 2 | 170 | 2 | 21164026 | |
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 2.38e-05 | 2 | 170 | 2 | 27758680 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 22387014 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 19862540 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 2.38e-05 | 2 | 170 | 2 | 23749435 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 23918728 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 2.38e-05 | 2 | 170 | 2 | 3037333 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 11726230 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 2.38e-05 | 2 | 170 | 2 | 6950384 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 1692292 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 26503236 | ||
| Interaction | DKKL1 interactions | TMPPE FAT4 PCDH20 ITIH2 NOMO1 HSPA13 HARS2 FAT1 LRP5 ATP1A3 ATP12A | 2.24e-09 | 111 | 168 | 11 | int:DKKL1 |
| Interaction | IL5RA interactions | HSPG2 LAMA5 NOMO1 HSPA13 TENM3 ICAM5 TMEM132A LRP5 C4A SDCBP | 8.93e-08 | 124 | 168 | 10 | int:IL5RA |
| Interaction | TOP3B interactions | ATMIN HSPG2 SH3RF1 EP400 KIF26A MTHFD1L LAMA5 ADGRL1 MIB2 NHSL1 ACTR1B ACTR1A KMT2C FAT1 SHANK2 PROM2 TMEM132A PKD1 ANKRD11 AHSG LRP4 LRP5 MAPKBP1 TSR3 ARRDC2 SPEN MYRF D2HGDH HCFC1 KLHL17 | 4.19e-06 | 1470 | 168 | 30 | int:TOP3B |
| Interaction | PRSS37 interactions | 5.92e-06 | 15 | 168 | 4 | int:PRSS37 | |
| Interaction | NXPH2 interactions | 7.45e-06 | 33 | 168 | 5 | int:NXPH2 | |
| Interaction | PDGFB interactions | 8.89e-06 | 88 | 168 | 7 | int:PDGFB | |
| Interaction | MGAT4C interactions | 1.52e-05 | 38 | 168 | 5 | int:MGAT4C | |
| Interaction | KCTD13 interactions | SART3 MICAL1 KRT19 DSP DOCK8 TNC CORO1C DPYSL4 ADGRL1 NCAM1 AP3B1 TRIM3 OPHN1 NHSL1 ACTR1A SHANK2 ICAM5 HECW2 EIF2S3 SIPA1L1 DLD KCNQ3 ATP1A1 ATP1A3 HSPA9 SDCBP ALDH7A1 | 3.42e-05 | 1394 | 168 | 27 | int:KCTD13 |
| Interaction | CMA1 interactions | 3.94e-05 | 46 | 168 | 5 | int:CMA1 | |
| Interaction | KCNMA1 interactions | 4.05e-05 | 196 | 168 | 9 | int:KCNMA1 | |
| Interaction | FBXO22 interactions | NOP56 MTHFD1L CORO1C TBC1D2B SRR KMT2C PTPRB ANKRD11 NID1 C4A C4B ATP1A1 SH3RF3 HCFC1 SDCBP | 4.85e-05 | 540 | 168 | 15 | int:FBXO22 |
| Interaction | PCDHGA7 interactions | 5.14e-05 | 25 | 168 | 4 | int:PCDHGA7 | |
| Interaction | CEACAM8 interactions | 6.32e-05 | 119 | 168 | 7 | int:CEACAM8 | |
| Interaction | LLCFC1 interactions | 7.02e-05 | 121 | 168 | 7 | int:LLCFC1 | |
| Interaction | MTDH interactions | HSPG2 CCDC8 NOP56 DSP TBC1D2B LAMA5 ESAM RIOX1 HSD3B7 EIF2S3 LRP1 LRP5 ENO1 FTSJ3 | 8.91e-05 | 505 | 168 | 14 | int:MTDH |
| Interaction | KLHL2 interactions | 1.01e-04 | 89 | 168 | 6 | int:KLHL2 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.23e-09 | 9 | 116 | 5 | 1234 | |
| GeneFamily | Cadherin related | 3.59e-06 | 17 | 116 | 4 | 24 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 8.84e-06 | 7 | 116 | 3 | 1208 | |
| GeneFamily | Low density lipoprotein receptors | 7.02e-05 | 13 | 116 | 3 | 634 | |
| GeneFamily | ATPase H+/K+ transporting | 1.22e-04 | 3 | 116 | 2 | 1211 | |
| GeneFamily | Immunoglobulin like domain containing | 2.48e-04 | 193 | 116 | 7 | 594 | |
| GeneFamily | Complement system|Sushi domain containing | 1.57e-03 | 36 | 116 | 3 | 492 | |
| GeneFamily | Fibronectin type III domain containing | 3.72e-03 | 160 | 116 | 5 | 555 | |
| GeneFamily | Ankyrin repeat domain containing | 4.72e-03 | 242 | 116 | 6 | 403 | |
| GeneFamily | Heat shock 70kDa proteins | 5.21e-03 | 17 | 116 | 2 | 583 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 7.63e-06 | 20 | 170 | 4 | MM17053 | |
| Coexpression | NABA_CORE_MATRISOME | 1.14e-05 | 270 | 170 | 10 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 1.34e-05 | 275 | 170 | 10 | M5884 | |
| Coexpression | AIZARANI_LIVER_C7_EPCAM_POS_BILE_DUCT_CELLS_2 | 1.39e-05 | 219 | 170 | 9 | M39111 | |
| Coexpression | VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 | 2.65e-05 | 54 | 170 | 5 | M4737 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_UP | 2.82e-05 | 184 | 170 | 8 | M9988 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.68e-05 | 191 | 170 | 8 | MM17059 | |
| Coexpression | AIZARANI_LIVER_C4_EPCAM_POS_BILE_DUCT_CELLS_1 | 3.68e-05 | 191 | 170 | 8 | M39108 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | SH3RF1 KRT19 DSP TNC INPP5A CORO1C FCHO2 CLSTN1 EDN1 KMT2C FAT1 PTPRB GTF2IRD2 UPP1 DSG4 ARHGEF37 ENO1 | 3.69e-05 | 843 | 170 | 17 | M2356 |
| Coexpression | GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_1DAY_STIMULATED_BCELL_DN | 4.26e-05 | 195 | 170 | 8 | M9819 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.42e-05 | 196 | 170 | 8 | M3008 | |
| Coexpression | GSE42021_TREG_VS_TCONV_PLN_DN | 4.92e-05 | 199 | 170 | 8 | M9574 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL | HSPG2 KRT19 MKNK2 TBC1D2B LAMA5 IER5 MIB2 NHSL1 NACC2 TMEM132A GADL1 C4A C4B MYRF PLXNB1 | 5.84e-05 | 704 | 170 | 15 | M45672 |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM | 7.55e-05 | 67 | 170 | 5 | M1686 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 7.64e-05 | 35 | 170 | 4 | MM17054 | |
| Coexpression | HOWARD_MONOCYTE_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN | 9.54e-05 | 37 | 170 | 4 | M41058 | |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM | 9.97e-05 | 71 | 170 | 5 | MM1210 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN | A2M CPAMD8 FAT4 SPARC TRIM2 VSIG1 ITGB2 OPRL1 ICAM5 TENM1 LRP1 LRP5 ARRDC2 SH3RF3 ALDH7A1 | 1.02e-04 | 740 | 170 | 15 | M41202 |
| Coexpression | JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 1.29e-04 | 75 | 170 | 5 | MM1143 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.30e-04 | 40 | 170 | 4 | M5887 | |
| Coexpression | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP | 1.46e-04 | 297 | 170 | 9 | MM1003 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.32e-09 | 195 | 170 | 10 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | SPARC EP400 KRT19 CLSTN1 EDN1 FAT1 GTF2IRD2 PKHD1 RHBDD3 PLXNB1 | 5.25e-09 | 199 | 170 | 10 | 174f6013af6eafa577f84205a62927f2b367fda3 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-08 | 184 | 170 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-08 | 184 | 170 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-08 | 184 | 170 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 4.74e-08 | 188 | 170 | 9 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.20e-08 | 194 | 170 | 9 | ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.20e-08 | 194 | 170 | 9 | cceb7c88492bb6cd531e1c2651638da1ddf30931 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.77e-08 | 196 | 170 | 9 | ed818de15f84f7f28bd06fd69d7876710da232a0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.77e-08 | 196 | 170 | 9 | e224338490691d92c1f70b57112fabdcc92b06a9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.07e-08 | 197 | 170 | 9 | c10dd1aaec01fb662eac83dfde90e3e426665d65 | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 7.07e-08 | 197 | 170 | 9 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.07e-08 | 197 | 170 | 9 | 2844dbcd0a673ed81c99920aa45858651a00736d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.38e-08 | 198 | 170 | 9 | 218f33e068eb126458ec33176de3cfa6fc06ddf0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.38e-08 | 198 | 170 | 9 | 72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.38e-08 | 198 | 170 | 9 | e1fa02184ce93c4f8aa5cf04b70949cd4c425ff0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.38e-08 | 198 | 170 | 9 | 7cddd474416651088a4e08edfc0ac420ff10a5fe | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.71e-08 | 199 | 170 | 9 | 9c40b3ee39860e9d8edafd007daec11abdd95435 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.71e-08 | 199 | 170 | 9 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.71e-08 | 199 | 170 | 9 | 72b34bce8157abe389e95cd3ed8ba578dce0cbf6 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.71e-08 | 199 | 170 | 9 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.71e-08 | 199 | 170 | 9 | 0602e2b2aa56d106da63bd342a38bef437b4d496 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.05e-08 | 200 | 170 | 9 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 8.05e-08 | 200 | 170 | 9 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-07 | 171 | 170 | 8 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-07 | 171 | 170 | 8 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | ASK428-Endothelial-Endothelium|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.87e-07 | 41 | 170 | 5 | a72d926de3dc9e420b80764af88002e436517790 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-07 | 182 | 170 | 8 | dc55de945c6f78f32eb3a1b3520835eb8417e068 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.15e-07 | 182 | 170 | 8 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-07 | 182 | 170 | 8 | 010a7364da46101cb5068891fd7bc712ea8f13bd | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.07e-07 | 186 | 170 | 8 | a906020a8df6fcca474b278f746c553b177a56b4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.32e-07 | 187 | 170 | 8 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class | 6.85e-07 | 189 | 170 | 8 | 8030a353473da34ae92429f2d822171a2e94248f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-07 | 190 | 170 | 8 | b7fc451e160e31dc898b122de844b501f587db67 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.13e-07 | 190 | 170 | 8 | 06bfb62b94b0faf467ef93d5bc5d08924c770098 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-07 | 190 | 170 | 8 | 83cc851fb9f644b17a8ebf4d99a646003769a22f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-07 | 190 | 170 | 8 | 5f440d4b334d66d419c03bd828f7d93f16c1ce67 | |
| ToppCell | facs-Thymus-Epithelium-3m-Endothelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-07 | 191 | 170 | 8 | 6676ef9aeb890668cb69e67865404061b8467c25 | |
| ToppCell | Basal_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 7.42e-07 | 191 | 170 | 8 | a98915bad9a4a61dd4cbca798914849b805f4a19 | |
| ToppCell | facs-Thymus-Epithelium-3m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-07 | 191 | 170 | 8 | a157cee0fbc9dce64308128c3578e7327fa178b7 | |
| ToppCell | facs-Thymus-Epithelium-3m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-07 | 191 | 170 | 8 | d2311a5b0cf186839000f9f272b6fbc2270ddb44 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-07 | 192 | 170 | 8 | f4cd65e6c5b17bcabf45fe5b687246c72e7975f7 | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 7.71e-07 | 192 | 170 | 8 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 7.71e-07 | 192 | 170 | 8 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 7.71e-07 | 192 | 170 | 8 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-07 | 192 | 170 | 8 | bcd8876235be503186f119653b39476488c0fa15 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.02e-07 | 193 | 170 | 8 | 3f8280ef849d95b2fcea5e6824b95a07febc96d0 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.34e-07 | 194 | 170 | 8 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.34e-07 | 194 | 170 | 8 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | ASK440-Endothelial-Endothelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.67e-07 | 195 | 170 | 8 | 304f0dc91bb57e98b0ca31d6bfb3ff9364e4da56 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.67e-07 | 195 | 170 | 8 | 4658fb197657d7692ee344ae76b11b0210c418ba | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.01e-07 | 196 | 170 | 8 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | ASK454-Endothelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.01e-07 | 196 | 170 | 8 | 14dd6956ef420b660be0baf52a66960e57d75d16 | |
| ToppCell | ASK454-Endothelial-Endothelium|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.01e-07 | 196 | 170 | 8 | 2b777a2026b56839112fd179f2db482c49f4594a | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 9.01e-07 | 196 | 170 | 8 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.01e-07 | 196 | 170 | 8 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.36e-07 | 197 | 170 | 8 | 62c0a90869431e582bb7bb329e0b0cc59123d3d1 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.36e-07 | 197 | 170 | 8 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.36e-07 | 197 | 170 | 8 | 16f0eb047df9d702518f82ee99c6e7dc1350b2fb | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.36e-07 | 197 | 170 | 8 | ca6bce1a92c6326f41a6300c31da02386bafa152 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.72e-07 | 198 | 170 | 8 | 92416e65a0dc1a4bf931833407620ea05d362f56 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 9.72e-07 | 198 | 170 | 8 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.72e-07 | 198 | 170 | 8 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | (4)_Endothelial_cells-(4)_Blood_vessel|(4)_Endothelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.01e-06 | 199 | 170 | 8 | e24d70e79f25cdd3300bf5e2322713355264d4c5 | |
| ToppCell | suprabasal_cell|World / shred by cell class for turbinate | 1.01e-06 | 199 | 170 | 8 | bfab5380ef074d14f0b5ed10851ad5c898eb9a58 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-06 | 199 | 170 | 8 | 463ba77dc4c85eebb343f29a42c7ac889b0497c9 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-06 | 200 | 170 | 8 | 2989325b0e78ab42f362cfb59e34a4fce7f8e869 | |
| ToppCell | Biopsy_Other_PF-Epithelial-KRT5-/KRT17+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.05e-06 | 200 | 170 | 8 | 077e6b9340686de9d0f11b035a8954e1f6a1b790 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.05e-06 | 200 | 170 | 8 | 77ac1aa73c16a4f595ff01c6b4e171e0b8fed1e6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.05e-06 | 200 | 170 | 8 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-06 | 200 | 170 | 8 | 86ec951234015ced7126b016199e5869a0f22478 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.05e-06 | 200 | 170 | 8 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.05e-06 | 200 | 170 | 8 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.05e-06 | 200 | 170 | 8 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.05e-06 | 200 | 170 | 8 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.05e-06 | 200 | 170 | 8 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-06 | 200 | 170 | 8 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-06 | 200 | 170 | 8 | 061ba851f941c616ddb462512e826c412881c3ce | |
| ToppCell | 3'-Adult-LymphNode-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-06 | 200 | 170 | 8 | 663e2b4672f193844bb9bf4873749114977c19b3 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.79e-06 | 160 | 170 | 7 | 33050dc646762dc7e9dcc4a12c618e1ba1ce5a4d | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.85e-06 | 168 | 170 | 7 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.50e-06 | 172 | 170 | 7 | c8ea80042faf923b08ff03d73100533d521d73ef | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.67e-06 | 173 | 170 | 7 | f193c63cc536d891c9d23043765e320252bb6e65 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 4.85e-06 | 174 | 170 | 7 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.23e-06 | 176 | 170 | 7 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.23e-06 | 176 | 170 | 7 | 77516048aefbe1f48e825052756df0c310c1c486 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.23e-06 | 176 | 170 | 7 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.23e-06 | 176 | 170 | 7 | 64e426f5e84884ce2c29acf6f4b958962a63927f | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.43e-06 | 177 | 170 | 7 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.06e-06 | 180 | 170 | 7 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.06e-06 | 180 | 170 | 7 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.06e-06 | 180 | 170 | 7 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-06 | 180 | 170 | 7 | be10fe5bf7c3a671c42704ce7dd8226ab6896794 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-06 | 180 | 170 | 7 | 3b747a517ce75ef2ff09011c037dad7b01ed3e03 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.28e-06 | 181 | 170 | 7 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.28e-06 | 181 | 170 | 7 | 3fe648db1cb8326066d8bde3ca1287c5c9af19bd | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.28e-06 | 181 | 170 | 7 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.51e-06 | 182 | 170 | 7 | 0639011cdd1c437ea8b7230896a4e6e5d7244ac2 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.51e-06 | 182 | 170 | 7 | 193cb2df3d7ea4cb9a11390b92955e7d9b0a053a | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.51e-06 | 182 | 170 | 7 | cc79e0cc21e2fdc4ef77f052818d27b9f707aec1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.41e-06 | 50 | 107 | 6 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_3 | |
| Computational | Intermediate filaments and MT. | 5.61e-05 | 68 | 107 | 6 | MODULE_438 | |
| Drug | Clotrimazole [23593-75-1]; Down 200; 11.6uM; PC3; HT_HG-U133A | TRIM2 TBC1D2B IL17RC AP3B1 MED25 SDC3 RHBDD3 PCCA IL17RB ALDH7A1 | 1.79e-06 | 193 | 168 | 10 | 5726_DN |
| Drug | 4-toluidine | SPARC HIVEP1 ACO1 MKNK2 ITIH2 ASB5 ANKRD11 LRP1 LRP5 NID1 MYRF CD99L2 EPB41 | 1.94e-06 | 347 | 168 | 13 | ctd:C029370 |
| Drug | R di | 4.86e-06 | 16 | 168 | 4 | CID005289274 | |
| Drug | chondroitin sulfate | A2M HSPG2 COL11A2 SPARC TNC LAMA5 NCAM1 ITIH2 PTPRB SDC3 NID1 C4A SDCBP | 1.27e-05 | 413 | 168 | 13 | CID000024766 |
| Drug | Nadolol [42200-33-9]; Up 200; 13uM; MCF7; HT_HG-U133A | HSPG2 TRIM2 ARHGEF28 ADGRL1 IL17RC HSPA13 SHANK2 MED25 PLXNB1 | 1.45e-05 | 194 | 168 | 9 | 4139_UP |
| Drug | PHA-00767505E [723337-45-9]; Up 200; 10uM; PC3; HT_HG-U133A | 1.51e-05 | 195 | 168 | 9 | 6545_UP | |
| Drug | Liothyronine [6893-02-3]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 1.57e-05 | 196 | 168 | 9 | 3324_DN | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; PC3; HT_HG-U133A | 1.64e-05 | 197 | 168 | 9 | 4547_DN | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; PC3; HT_HG-U133A | 1.64e-05 | 197 | 168 | 9 | 6663_DN | |
| Drug | norethisterone oenanthate | 1.66e-05 | 109 | 168 | 7 | CID000019688 | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 1.14e-10 | 7 | 167 | 5 | DOID:0060178 (implicated_via_orthology) | |
| Disease | nervous system disease (implicated_via_orthology) | 4.19e-09 | 12 | 167 | 5 | DOID:863 (implicated_via_orthology) | |
| Disease | MEHMO syndrome (implicated_via_orthology) | 3.18e-05 | 2 | 167 | 2 | DOID:0060801 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 4.17e-05 | 163 | 167 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 6.19e-05 | 14 | 167 | 3 | DOID:10976 (biomarker_via_orthology) | |
| Disease | autosomal recessive limb-girdle muscular dystrophy type 2H (implicated_via_orthology) | 9.52e-05 | 3 | 167 | 2 | DOID:0110282 (implicated_via_orthology) | |
| Disease | autosomal recessive limb-girdle muscular dystrophy (implicated_via_orthology) | 9.52e-05 | 3 | 167 | 2 | DOID:0110274 (implicated_via_orthology) | |
| Disease | triacylglycerol 56:6 measurement | 1.03e-04 | 43 | 167 | 4 | EFO_0010433 | |
| Disease | autosomal dominant polycystic kidney disease (is_implicated_in) | 1.90e-04 | 4 | 167 | 2 | DOID:898 (is_implicated_in) | |
| Disease | Degenerative polyarthritis | 1.90e-04 | 93 | 167 | 5 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 1.90e-04 | 93 | 167 | 5 | C0086743 | |
| Disease | Colorectal Carcinoma | ABCC1 CPAMD8 SPARC MTHFD1L CSMD3 KMT2C FAT1 ICAM5 PKHD1 TENM1 LRP1 NID1 PZP | 1.92e-04 | 702 | 167 | 13 | C0009402 |
| Disease | abdominal adipose tissue measurement | 2.33e-04 | 53 | 167 | 4 | EFO_0803316 | |
| Disease | glucagon measurement | 2.53e-04 | 154 | 167 | 6 | EFO_0008463 | |
| Disease | Cartilage Diseases | 4.71e-04 | 6 | 167 | 2 | C0007302 | |
| Disease | hypopituitarism (implicated_via_orthology) | 4.71e-04 | 6 | 167 | 2 | DOID:9406 (implicated_via_orthology) | |
| Disease | Chondromalacia | 4.71e-04 | 6 | 167 | 2 | C0085700 | |
| Disease | polycystic liver disease (implicated_via_orthology) | 6.56e-04 | 7 | 167 | 2 | DOID:0050770 (implicated_via_orthology) | |
| Disease | osteonecrosis (biomarker_via_orthology) | 6.56e-04 | 7 | 167 | 2 | DOID:10159 (biomarker_via_orthology) | |
| Disease | cytomegalovirus infection, response to allogeneic hematopoietic stem cell transplant | 8.72e-04 | 8 | 167 | 2 | EFO_0001062, EFO_0007044 | |
| Disease | oppositional defiant disorder measurement | 1.11e-03 | 36 | 167 | 3 | EFO_0007679 | |
| Disease | leukodystrophy (implicated_via_orthology) | 1.12e-03 | 9 | 167 | 2 | DOID:10579 (implicated_via_orthology) | |
| Disease | Nonsyndromic Deafness | 1.17e-03 | 81 | 167 | 4 | C3711374 | |
| Disease | Asthma, Occupational | 1.39e-03 | 10 | 167 | 2 | C0264423 | |
| Disease | membranoproliferative glomerulonephritis (biomarker_via_orthology) | 1.39e-03 | 10 | 167 | 2 | DOID:2920 (biomarker_via_orthology) | |
| Disease | unipolar depression | MICAL1 SP4 TNC NCAM1 CSMD3 FAT1 EXD3 CNTNAP5 SHANK2 PKD1 PKHD1 DLD KCNQ3 ARHGEF37 PZP KLHDC8B | 1.41e-03 | 1206 | 167 | 16 | EFO_0003761 |
| Disease | cups of coffee per day measurement | 1.51e-03 | 40 | 167 | 3 | EFO_0006782 | |
| Disease | autistic disorder (is_implicated_in) | 1.74e-03 | 42 | 167 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | Autoimmune Diseases | 1.74e-03 | 42 | 167 | 3 | C0004364 | |
| Disease | Neurodevelopmental Disorders | 1.95e-03 | 93 | 167 | 4 | C1535926 | |
| Disease | Squamous cell carcinoma of esophagus | 2.11e-03 | 95 | 167 | 4 | C0279626 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 2.12e-03 | 45 | 167 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | peak expiratory flow | 2.21e-03 | 498 | 167 | 9 | EFO_0009718 | |
| Disease | hearing impairment | 2.37e-03 | 98 | 167 | 4 | C1384666 | |
| Disease | Connective Tissue Diseases | 2.38e-03 | 13 | 167 | 2 | C0009782 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 2.77e-03 | 14 | 167 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | Nephrosis | 3.19e-03 | 15 | 167 | 2 | C0027720 | |
| Disease | response to olanzapine | 3.19e-03 | 15 | 167 | 2 | GO_0097333 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 3.63e-03 | 16 | 167 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (18:0_20:3) in blood serum | 3.63e-03 | 16 | 167 | 2 | OBA_2045093 | |
| Disease | asthma, response to diisocyanate | 3.81e-03 | 261 | 167 | 6 | EFO_0006995, MONDO_0004979 | |
| Disease | Necrotizing Enterocolitis | 4.10e-03 | 17 | 167 | 2 | C0520459 | |
| Disease | Van Buchem disease | 4.10e-03 | 17 | 167 | 2 | C0432272 | |
| Disease | cortical thickness | A2M HSPG2 CPAMD8 CORO1C DPYSL4 NCAM1 NHSL1 ACTR1B PKD1 PKHD1 LRP1 LRP4 PCCA SH3RF3 | 4.48e-03 | 1113 | 167 | 14 | EFO_0004840 |
| Disease | blood nickel measurement | 4.89e-03 | 120 | 167 | 4 | EFO_0007583 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 5.11e-03 | 19 | 167 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | kidney failure (biomarker_via_orthology) | 5.11e-03 | 19 | 167 | 2 | DOID:1074 (biomarker_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.15e-03 | 195 | 167 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | Squamous cell carcinoma | 5.49e-03 | 124 | 167 | 4 | C0007137 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PVVEAITQGDLVAVG | 516 | P21399 | |
| SGNVIVNTIAGVPAA | 2631 | Q96L91 | |
| APAITQGQVAEGGVL | 561 | P11171 | |
| SLVGNRAPVAIGVAA | 136 | P41214 | |
| VANGVEISVPVPSDA | 306 | Q9Y6Q5 | |
| PGVINGGDVSTVVAE | 2171 | Q6UB99 | |
| GAELGVRNAASVTPV | 266 | Q86SG2 | |
| LAAAIQEVTQPGAGV | 171 | A6NC98 | |
| QEVTQPGAGVVLALS | 176 | A6NC98 | |
| VPEGAGIQVQVVSFA | 1971 | Q7Z407 | |
| VGFEAVQEVPVGLVQ | 1536 | P0C0L5 | |
| ATVFPAGLANVVTGD | 711 | Q8IZ83 | |
| VNVNIPTSGAEIGGA | 481 | P49419 | |
| AAGIVESIGPGVTNV | 71 | P08319 | |
| QGIVEAVVPQAGSSG | 146 | A1IGU5 | |
| GPVRVTAIQGDVTQA | 56 | Q9H2F3 | |
| PGGASLVVNSQVIAA | 756 | O94910 | |
| SVLSNIQVVVPVDGG | 701 | Q0JRZ9 | |
| QAGVPEDAVVGSSVL | 256 | Q6V0I7 | |
| GEPIGTNVISIEAAS | 1641 | Q6V0I7 | |
| IIANQPVVIDNGSGV | 6 | P42025 | |
| VNPRFVAIIIEASGG | 41 | Q9ULV4 | |
| VAVVQEDGPQVAGSN | 176 | Q9NZW4 | |
| SAQPVLAVAGGVTQL | 251 | P18850 | |
| NGTQAVRIPDGVVSV | 366 | O94985 | |
| QPVTADDLGVTGALT | 641 | Q6UB35 | |
| LQGAIVDVFSRAGPV | 21 | Q569K6 | |
| PGSEVVQVQARGVDL | 251 | A6H8M9 | |
| VQLDGATAGVEPVFS | 11 | Q8TBH0 | |
| VNSAGVAEVGVTVPD | 746 | P01023 | |
| STGVDQLVVTAGPAA | 536 | Q9Y2G4 | |
| VVNVANVGAVPSGQD | 1026 | O00203 | |
| VVEEAVGQALPGATV | 301 | Q9NP87 | |
| AVNSSGVAEVGVTVP | 751 | P20742 | |
| GDGVPEAVVTLNNQI | 341 | P69849 | |
| VGSAEAFAQLLVQGP | 3371 | P98160 | |
| PDIVAGNAGEITSSV | 761 | O60890 | |
| PGIQGVVTDLAVSDA | 1341 | Q8N1W1 | |
| SPEAVGTILGVNSVN | 331 | Q9P2P5 | |
| DPQGGVIAILSTTDA | 2931 | Q14517 | |
| SAEGQEGQATTIPIV | 1671 | P51610 | |
| QDPTEVNVGGSVDIV | 746 | O60500 | |
| GNATVGTPIAAVQAV | 331 | Q8N6Y1 | |
| QVAPSLSALIGEAVG | 291 | O00567 | |
| GDGVPEAVVTLNNQI | 341 | Q5JPE7 | |
| GRTVPASVQGVIADN | 991 | P23467 | |
| QTGVGQREEAAAVLP | 551 | Q16849 | |
| SEQTRAVVEGGAIQP | 146 | A9QM74 | |
| GQVSVEVDSAPGTDL | 231 | P08727 | |
| VNGQESTPGIVPDAV | 566 | Q8NEZ4 | |
| GDVQAVPVSALTGDN | 316 | P46199 | |
| VSDPESGIVVNGQLV | 731 | P19823 | |
| GTGVETVVSADLPNA | 1646 | Q07954 | |
| VVAVTGDGVNDSPAL | 726 | P54707 | |
| IVAVTGDGVNDSPAL | 711 | P05023 | |
| LIASVPVVAVGNQGN | 206 | O43525 | |
| GAAVQNVVISGLVSP | 96 | O75197 | |
| VIPVTGDSEGATVQL | 236 | Q9NRM6 | |
| VTGISGATAENVPVE | 321 | O95786 | |
| VTEDQAGVSNVGLGP | 616 | Q86SJ6 | |
| NGVIAGVAPSVEAFD | 36 | P40123 | |
| QADVVPINITASGTG | 216 | Q5SYE7 | |
| GVEVSDIGSQDAPII | 376 | Q06265 | |
| NDPAVSTVGLVAQGL | 146 | O43157 | |
| AAPGTAVLLVTANVG | 6 | Q14642 | |
| AGAQALVTLEGVPAA | 346 | Q9UMF0 | |
| EEAAGQGQPVLVRAT | 416 | Q9HBH9 | |
| VEESEPGTLVGNVAQ | 36 | Q9Y5F6 | |
| TNGVVPADVILGTED | 271 | P14543 | |
| GDGVPEAVVTLNNQI | 341 | Q15155 | |
| FEGDVQELAIVPGVQ | 201 | P13942 | |
| ISVAASAAIPGPQEV | 1866 | Q9ULI4 | |
| VSAQAVVAGSDPLGL | 586 | Q8TDZ2 | |
| ADVVFVIEGTANLGP | 16 | Q71SY5 | |
| PSVAVEASGGITLDN | 241 | Q15274 | |
| VALEVASPAGQGALA | 1811 | O15230 | |
| GTVVALISVQDPDSG | 366 | Q9Y5F7 | |
| VAVSVKPGDAVAEGQ | 671 | P05165 | |
| VNPDEAVAIGAAIQG | 411 | P38646 | |
| VGSDGNPEDVTVILN | 2576 | Q96RW7 | |
| VAGPNIAAIVGGTVA | 696 | P05107 | |
| GAPAVVISQGRVALE | 441 | O14531 | |
| AGIQVVGDDLTVTNP | 311 | P06733 | |
| ADSSAQPVVLGVDQG | 321 | O43313 | |
| QPVVLGVDQGSATGA | 326 | O43313 | |
| EVPISNGSGFVVAAD | 176 | O43464 | |
| VVGEGNVQTLLPAAS | 156 | Q6TDP4 | |
| GLAGALASNPVDVVR | 211 | Q5SVS4 | |
| VGATVNQGPLEVAQV | 1981 | Q8NF50 | |
| VAEPGTIAGVASALA | 181 | Q8TCZ2 | |
| TVVQPSVGAAAGPVV | 341 | P02765 | |
| VNGVLTALPVSVADG | 1756 | Q9Y6R7 | |
| PVSVADGRISVAQGA | 4166 | Q9Y6R7 | |
| LVAIGTAVTAAVNPG | 21 | P17213 | |
| ITVLEAGTQAPEGVA | 321 | Q96JB5 | |
| LVAQGEPVVQSQGAI | 66 | Q8IZJ3 | |
| EAQIASGGVVDPVNS | 2126 | P15924 | |
| VIANQPVVIDNGSGV | 6 | P61163 | |
| GANVNAITIDGVTPL | 126 | Q8WWX0 | |
| ADQPIDADVTVIGSG | 36 | P09622 | |
| NVTLEVSTGPGAAVV | 236 | Q96AP7 | |
| QELEAVAGAVLSSPG | 1466 | O60336 | |
| IVAVTGDGVNDSPAL | 701 | P13637 | |
| VLVVGGVDEVQSPVA | 81 | Q8IXV7 | |
| DTPVGTIIGAVTAQD | 396 | P55289 | |
| DPDLAVVTGVAIQAG | 431 | P48723 | |
| PAVGGNEGVAQVVAV | 101 | Q9BV79 | |
| NAVLVDGVVLNGPTT | 26 | Q6ZQY3 | |
| QILAFVQGTVAEGAP | 206 | Q2VIR3 | |
| SAVVVQGLPEGVAFQ | 141 | Q86UP8 | |
| SAVVVQGLPEGVAFQ | 141 | Q6EKJ0 | |
| VAALDANGIIVEGPV | 96 | Q12864 | |
| AGAPGIQEAEVSAAQ | 446 | Q9H0W5 | |
| QGAPETAVLGAELSA | 16 | P05305 | |
| QPDTANEVVAVGGAA | 326 | O75056 | |
| IRANVAVVSGAPLQG | 66 | O00560 | |
| IPAAGETQNVEVAAG | 651 | Q15020 | |
| AIVAVTGDGVNDSPA | 721 | P20648 | |
| AIDVGNGPVELVVQS | 851 | Q8WYK1 | |
| VGFEAVQEVPVGLVQ | 1536 | P0C0L4 | |
| GGVVTDPEALQAPNV | 76 | Q8N465 | |
| PAALVQFGQSVGSVV | 216 | Q8NAC3 | |
| LPSVAVGVSDGVLVA | 1126 | P98161 | |
| GAPVVVSAAVQTGDN | 1226 | P98161 | |
| TGASGIVEVLTEVPN | 576 | Q96AX9 | |
| VAGTAAEQVPVSPLA | 1711 | Q6ZRI0 | |
| QGLGVQPSSETAVAI | 286 | P41146 | |
| FSIPEGALVAVVGQV | 666 | P33527 | |
| EVPVATVTGVGDVFQ | 116 | Q5VY09 | |
| QAAAAVGPTVLEGQV | 466 | Q8N2Y8 | |
| GLEPGTVVITEQAVD | 146 | Q16831 | |
| APSDIVAAGVVLGSI | 306 | Q8N808 | |
| APVTVAVGGIANATI | 576 | Q02446 | |
| TQAGEEPLNVGSVAA | 346 | P49590 | |
| NAELSQAVVDAGAVP | 156 | O75602 | |
| SQLVVNAGGVAAVID | 286 | O75602 | |
| PAEEQGAQLGVVVSG | 716 | Q24JP5 | |
| VGAPAVQSILVAGEE | 981 | Q24JP5 | |
| IVIPGGVNATNGTEA | 156 | P58743 | |
| VDVVLNDGAPNVGAS | 111 | Q8IY81 | |
| IGNDIVTIVFQEPGA | 706 | O43166 | |
| AAVESAVAGPQGREQ | 46 | Q9UHJ6 | |
| GQVVAIDGTPLVGVN | 891 | Q9UKZ4 | |
| VFTPVINGVGGNLVA | 351 | Q8IVJ1 | |
| IVPTGNGSVALEIEV | 1626 | P08F94 | |
| EPAVIAGQGTIALEV | 156 | Q9GZT4 | |
| GVNEPDVLAINGASV | 161 | Q8TCS8 | |
| IGTVLSVPGNAAVDL | 431 | A4IF30 | |
| EAGEPVNVGAQLTTE | 531 | Q9H6W3 | |
| NGVAGSPSVVPAAVV | 546 | Q7Z6J0 | |
| GVSETEGALQISAAP | 1351 | Q9UPX8 | |
| AVVAVTGDGVNDSPA | 716 | Q13733 | |
| GSAEQLQVGPVAVRV | 651 | Q8IUL8 | |
| QVDIVPSQGEISVGE | 21 | P13591 | |
| GFPTEQAVVALAATG | 336 | Q9Y3P4 | |
| GLAGALASNPVDVVR | 246 | O95258 | |
| AGQVSVVQVTIPDGF | 16 | Q86XK7 | |
| AAAIGSIINDISGEP | 2216 | Q96T58 | |
| AVAQQPEGVRTLAEG | 376 | Q8N271 | |
| AVDALLQGAVGPEVS | 751 | Q8TEJ3 | |
| VSVGANPVQVEVGEF | 41 | P09486 | |
| DDFRQSPGNVVVAVG | 166 | Q96MS0 | |
| STGETPNLGEVVVAE | 1161 | P24821 | |
| QVTTDGEISLVAGIP | 1431 | Q9P273 | |
| AGLVVVPVALNSGVS | 771 | Q6ZSY5 | |
| DVVSGSQPAEGLVAN | 91 | Q9Y2L5 | |
| SQPAEGLVANVITAG | 96 | Q9Y2L5 | |
| PEQLADGATQVVVVG | 1931 | Q9C0G0 | |
| APTGVAVDSNGNIIV | 671 | Q9C040 | |
| VETVPGELVGEQAAN | 191 | Q9UPU7 | |
| PSVSQVAVDAQGAPE | 2556 | P15822 | |
| EVGAALQASVEPGAA | 31 | Q9UJK0 | |
| PTGVAVDTNGDIIVA | 536 | O75382 | |
| APTGVAVDSNGNIIV | 671 | O75382 | |
| PALAVGVTAVLSVAG | 166 | Q6ZT21 | |
| QILAFVQGTVAEGAP | 206 | P41091 | |
| GQEVVVDTSLESPAG | 806 | O75096 | |
| EVDGAGSVIQEVAAP | 531 | Q96BF6 | |
| VPVAVAVSEGAAPQI | 611 | Q8N9H8 | |
| GIEATAPETGVIAQE | 626 | Q9Y2G1 |